Save your place

Sign in to WhoBought

Please try again later.

Precision BioSciences, Inc. (DTIL) institutional ownership

Latest close $6.89 Jul 29, 2026
Market cap$65M 52-week range SectorHealthcare
Funds holding · Q1 2024
65
reported DTIL position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2024
Activity unavailable N/A
0 buyers · 65 sellers

Precision BioSciences, Inc. (DTIL) price and institutional activity

Dates

Q1 2024

$0 bought by 0 investors
$0 sold by 65 investors
Capital World InvestorsVanguard +63 more
Bought Sold Totals per quarter; hover a bar for the names.

Precision BioSciences, Inc. (DTIL) institutional activity · 65

Investor Type Est. change Change Δ Own Date
Capital World Investors · Exited
Change −5.1M Δ Own −100.0% Date Q1 2024
Capital World Investors Exited· Q1 2024 −5.1M −100.0% Q1 2024
Vanguard · Exited
Change −4.8M Δ Own −100.0% Date Q1 2024
Vanguard Exited· Q1 2024 −4.8M −100.0% Q1 2024
Citadel Advisors LLC Exited· Q1 2024 −3.5M −100.0% Q1 2024
Tang Capital Management LLC · Exited
Change −3.4M Δ Own −100.0% Date Q1 2024
Tang Capital Management LLC Exited· Q1 2024 −3.4M −100.0% Q1 2024
Acadian Asset Management LLC · Exited
Change −3.3M Δ Own −100.0% Date Q1 2024
Acadian Asset Management LLC Exited· Q1 2024 −3.3M −100.0% Q1 2024
Renaissance Technologies LLC Exited· Q1 2024 −2.6M −100.0% Q1 2024
Stifel Financial Corp · Exited
Change −1.5M Δ Own −100.0% Date Q1 2024
Stifel Financial Corp Exited· Q1 2024 −1.5M −100.0% Q1 2024
BlackRock · Exited
Change −1.1M Δ Own −100.0% Date Q1 2024
BlackRock Exited· Q1 2024 −1.1M −100.0% Q1 2024
Geode · Exited
Change −895K Δ Own −100.0% Date Q1 2024
Geode Exited· Q1 2024 −895K −100.0% Q1 2024
Moloney Securities Asset Management, LLC · Exited
Change −890K Δ Own −100.0% Date Q1 2024
Moloney Securities Asset Management, LLC Exited· Q1 2024 −890K −100.0% Q1 2024
Bank of America Corp · Exited
Change −861K Δ Own −100.0% Date Q1 2024
Bank of America Corp Exited· Q1 2024 −861K −100.0% Q1 2024
Tejara Capital Ltd · Exited
Change −743K Δ Own −100.0% Date Q1 2024
Tejara Capital Ltd Exited· Q1 2024 −743K −100.0% Q1 2024
Blue Owl Capital Holdings LP · Exited
Change −607K Δ Own −100.0% Date Q1 2024
Blue Owl Capital Holdings LP Exited· Q1 2024 −607K −100.0% Q1 2024
Two Sigma Advisers, LP · Exited
Change −500K Δ Own −100.0% Date Q1 2024
Two Sigma Advisers, LP Exited· Q1 2024 −500K −100.0% Q1 2024
Goldman Sachs Group Inc · Exited
Change −494K Δ Own −100.0% Date Q1 2024
Goldman Sachs Group Inc Exited· Q1 2024 −494K −100.0% Q1 2024
Data through Q1 2024 · filed Jun 3, 2024
15 of 65

Famous investor activity in Precision BioSciences, Inc. (DTIL)

Precision BioSciences, Inc. (DTIL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Brown Melinda · Director Grant (A) 21K
Owned 21K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Brown Melinda Director Grant (A) 21K 21K Jun 3, 2026 Jun 5, 2026
Frankel Stanley · Director Grant (A) 21K
Owned 21K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Frankel Stanley Director Grant (A) 21K 21K Jun 3, 2026 Jun 5, 2026
Germano Geno J. · Director Grant (A) 21K
Owned 21K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Germano Geno J. Director Grant (A) 21K 21K Jun 3, 2026 Jun 5, 2026
Pire Shari Lisa · Director Grant (A) 21K
Owned 21K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Pire Shari Lisa Director Grant (A) 21K 21K Jun 3, 2026 Jun 5, 2026
Buehler Kevin · Director Grant (A) 21K
Owned 21K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Buehler Kevin Director Grant (A) 21K 21K Jun 3, 2026 Jun 5, 2026
Smith J. Jefferson · Officer Grant (A) 57K
Owned 57K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Smith J. Jefferson Officer Grant (A) 57K 57K Jun 1, 2026 Jun 3, 2026
Scimeca Dario · Officer Grant (A) 108K
Owned 108K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Scimeca Dario Officer Grant (A) 108K 108K Jun 1, 2026 Jun 3, 2026
Kelly John Alexander · CFO Grant (A) 194K
Owned 194K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Kelly John Alexander CFO Grant (A) 194K 194K Jun 1, 2026 Jun 3, 2026
Amoroso Michael · Director Grant (A) 574K
Owned 574K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Amoroso Michael Director Grant (A) 574K 574K Jun 1, 2026 Jun 3, 2026
Buehler Kevin · Director 2 operations 0
Owned 0 Trade date May 20, 2026 Filed date May 22, 2026
Buehler Kevin Director 2 operations 0 0 May 20, 2026 May 22, 2026
Frankel Stanley · Director 2 operations 0
Owned 0 Trade date May 20, 2026 Filed date May 22, 2026
Frankel Stanley Director 2 operations 0 0 May 20, 2026 May 22, 2026
Brown Melinda · Director 2 operations 0
Owned 0 Trade date May 20, 2026 Filed date May 22, 2026
Brown Melinda Director 2 operations 0 0 May 20, 2026 May 22, 2026
Pire Shari Lisa · Director 2 operations 0
Owned 0 Trade date May 20, 2026 Filed date May 22, 2026
Pire Shari Lisa Director 2 operations 0 0 May 20, 2026 May 22, 2026
Germano Geno J. · Director 2 operations 0
Owned 0 Trade date May 20, 2026 Filed date May 22, 2026
Germano Geno J. Director 2 operations 0 0 May 20, 2026 May 22, 2026
Amoroso Michael · Director, Officer Sell −$79K
Price $3.84 Qty −21K Owned 243K Trade date Feb 18, 2026 Filed date Feb 19, 2026
Amoroso Michael Director, Officer Sell $3.84 −21K −$79K 243K Feb 18, 2026 Feb 19, 2026
15 of 22
15 of 22 Sign in to continue to older insider transactions.

Precision BioSciences, Inc. (DTIL) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Octagon Capital Advisors LP 2.3M
% of shares outstanding 10.0% Filing date Feb 10, 2026
Octagon Capital Advisors LP 2.3M 10.0% Feb 10, 2026
Janus Henderson Group PLC 702K
% of shares outstanding 9.7% Filing date Nov 14, 2024
Janus Henderson Group PLC 702K 9.7% Nov 14, 2024
Readout Capital, LP 1.1M
% of shares outstanding 9.3% Filing date Aug 14, 2025
Readout Capital, LP 1.1M 9.3% Aug 14, 2025
Aberdeen Group PLC 2.1M
% of shares outstanding 8.9% Filing date Jan 27, 2026
Aberdeen Group PLC 2.1M 8.9% Jan 27, 2026
Bleichroeder LP 1.9M
% of shares outstanding 8.2% Filing date Feb 13, 2026
Bleichroeder LP 1.9M 8.2% Feb 13, 2026
Empery Asset Management, LP 2.0M
% of shares outstanding 7.6% Filing date Apr 15, 2026
Empery Asset Management, LP 2.0M 7.6% Apr 15, 2026
Perceptive Advisors LLC 426K
% of shares outstanding 5.9% Filing date Nov 14, 2024
Perceptive Advisors LLC 426K 5.9% Nov 14, 2024
Great Point Partners LLC 5.8M
% of shares outstanding 5.9% Filing date Jul 1, 2022
Great Point Partners LLC 5.8M 5.9% Jul 1, 2022
8 of 23

Precision BioSciences, Inc. (DTIL) ownership FAQ

Who owns DTIL?

65 reporting institutions disclosed DTIL position changes in the Q1 2024 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2024.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.